Skip to content
News & Events

News & Events

Impact of a multivariate serum-based proteomic test on physician treatment recommendations for advanced non-small-cell lung cancer.

The VeriStrat 1 (VS) test is intended to help guide treatment decisions for patients with advanced non-small-cell lung cancer (NSCLC) without an EGFR-sensitizing mutation, classifying… Impact of a multivariate serum-based proteomic test on physician treatment recommendations for advanced non-small-cell lung cancer.